Bloomberg News reports that Montana is the 7th state to file suit against Eli Lilly for its Zyprexa marketing practices. The other states are: Pennsylvania, Louisiana, West Virginia, Alaska, New Mexico and Mississippi. More than twenty are investigating.
According to the complaint filed on March 7 by Montana Attorney General Mike McGrath, “Lilly allegedly gave kickbacks to doctors and improperly promoted the drug to nursing homes as a sedative.” He claimed Lilly, the world’s biggest maker of psychiatric drugs, bought off a “disgruntled” sales director to keep him from disclosing its marketing practices. According to the complaint, Lilly “instructed its representatives to minimize and misrepresent the dangers of Zyprexa, affirmatively and consciously placing company profits above the public safety. This failure to warn was designed and intended to maximize company profits.”
The Montana suit charges: “Lilly management participated, encouraged and authorized the unlawful payment of illegal kickbacks to physicians in order to continue generating sales of Zyprexa.”
The state seeks “all funds spent by Montana or its citizens on Zyprexa since its launch in 1996, treble damages and attorneys’ fees.”
The entire article can be read here.
Thanks to the AHRP for this item.